Given that no therapeutic methods of postoperative adjuvant chemotherapy for non-small-cell lung cancer have been established, we selected UFT (tegafur and uracil) for investigation because UFT is less injurious to the host
Fumihiro Tanaka, MD
Advertisement
Articles by Fumihiro Tanaka, MD
Advertisement
Latest Updated Articles
- Postoperative Adjuvant Chemotherapy for Non-Small-Cell Lung Cancer
Published: September 2nd 1997 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
How Will Gastrointestinal Cancer Standards of Care Change? An ESMO Recap
2
Sac-TMT Combo Produces Encouraging Activity in Pretreated Metastatic CRPC
3
Zurletrectinib Generates Responses in Advanced NTRK Fusion Solid Tumors
4
Atezolizumab Combo Elicits No Significant Benefit in Ovarian Cancer
5
